Integra Lifesciences Holdings (IART) Convertible Debt (2009 - 2024)
Integra Lifesciences Holdings (IART) posted Convertible Debt of $571.7 million for Q2 2024, little changed sequentially from $571.0 million in Q1 2024, and up 0.51% YoY from $568.8 million in Q3 2023.
Integra Lifesciences Holdings (IART) Convertible Debt (2009 - 2024) Analysis & Trends
Integra Lifesciences Holdings has reported Convertible Debt for 13 years, with the latest figure at $571.7 million in Q2 2024.
- Quarterly Convertible Debt rose 0.51% year-over-year to $571.7 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $571.7 million (up 0.51% YoY) and the FY2023 annual result came in at $570.3 million, up 0.51% from the prior year.
- Convertible Debt was little changed at $571.7 million in Q2 2024 per IART's latest filing, from $571.0 million in the prior quarter.
- Over five years, Convertible Debt peaked at $571.7 million in Q2 2024 and troughed at $89.1 million in Q4 2020.
- A 5-year average of $523.4 million and a median of $565.5 million in 2022 frame the typical range for Convertible Debt.
- The sharpest annual moves came in 2021 and 2024: Convertible Debt surged 533.47% in 2021, then grew 0.51% in 2024.
- Over 5 years, Convertible Debt stood at $89.1 million in 2020, then soared by 533.47% to $564.4 million in 2021, then grew by 0.52% to $567.3 million in 2022, then rose by 0.51% to $570.3 million in 2023, then climbed by 0.26% to $571.7 million in 2024.
- According to Business Quant data, Convertible Debt over the past three periods registered $571.7 million, $571.0 million, and $570.3 million for Q2 2024, Q1 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 571.71 Mn |
| Mar 31, 2024 | 570.98 Mn |
| Dec 31, 2023 | 570.26 Mn |
| Sep 30, 2023 | 569.53 Mn |
| Jun 30, 2023 | 568.80 Mn |
| Mar 31, 2023 | 568.07 Mn |
| Dec 31, 2022 | 567.34 Mn |
| Sep 30, 2022 | 566.61 Mn |
| Jun 30, 2022 | 565.88 Mn |
| Mar 31, 2022 | 565.16 Mn |
| Dec 31, 2021 | 564.43 Mn |
| Sep 30, 2021 | 563.70 Mn |
| Jun 30, 2021 | 562.97 Mn |
| Mar 31, 2021 | 562.24 Mn |
| Dec 31, 2020 | 89.10 Mn |
| Sep 30, 2020 | 469.90 Mn |
| Jun 30, 2020 | 465.01 Mn |
| Mar 31, 2020 | 460.16 Mn |
| Sep 30, 2016 | 225.25 Mn |
| Jun 30, 2016 | 223.04 Mn |